Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 May;41(5):1120–1123. doi: 10.1128/aac.41.5.1120

Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis.

M H Nguyen 1, L K Najvar 1, C Y Yu 1, J R Graybill 1
PMCID: PMC163860  PMID: 9145879

Abstract

This study elucidates the role of combined fluconazole and flucytosine as therapy for cryptococcosis in the murine model of meningitis. Three strains of Cryptococcus neoformans for which the range of fluconazole MICs was wide--2 microg/ml (susceptible strain), 8 microg/ml (moderately susceptible strain), and 32 microg/ml (resistant strain)--were used for infection. One day postinfection, the mice were randomized into eight treatment groups: placebo; flucytosine (40 mg/kg of body weight/day); fluconazole at 3 mg/kg/day (low dosage), 10 mg/kg/day (moderate dosage), or 20 mg/kg/day (high dosage); and combined flucytosine and fluconazole at low, moderate, or high doses of fluconazole. Three major findings were demonstrated: (i) correlation between the MICs for the isolates and the in vivo effectiveness of fluconazole as assessed by the reduction in cryptococcal brain burden, (ii) a dose-response curve (a higher dose of fluconazole was significantly more efficacious than a lower dose [P < 0.001]), and (iii) synergism between fluconazole and flucytosine (therapy with a combination of fluconazole and flucytosine was superior to therapy with either agent alone [P < 0.01]).

Full Text

The Full Text of this article is available as a PDF (223.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allendoerfer R., Marquis A. J., Rinaldi M. G., Graybill J. R. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. Antimicrob Agents Chemother. 1991 Apr;35(4):726–729. doi: 10.1128/aac.35.4.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berenbaum M. C. A method for testing for synergy with any number of agents. J Infect Dis. 1978 Feb;137(2):122–130. doi: 10.1093/infdis/137.2.122. [DOI] [PubMed] [Google Scholar]
  3. Edelstein H. Multidermatomal herpes zoster in an AIDS patient. Clin Infect Dis. 1994 Nov;19(5):975–975. doi: 10.1093/clinids/19.5.975. [DOI] [PubMed] [Google Scholar]
  4. Kartalija M., Kaye K., Tureen J. H., Liu Q., Täuber M. G., Elliott B. R., Sande M. A. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. J Infect Dis. 1996 May;173(5):1216–1221. doi: 10.1093/infdis/173.5.1216. [DOI] [PubMed] [Google Scholar]
  5. Larsen R. A., Leal M. A., Chan L. S. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med. 1990 Aug 1;113(3):183–187. doi: 10.7326/0003-4819-113-3-183. [DOI] [PubMed] [Google Scholar]
  6. Nguyen M. H., Barchiesi F., McGough D. A., Yu V. L., Rinaldi M. G. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother. 1995 Aug;39(8):1691–1695. doi: 10.1128/aac.39.8.1691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Saag M. S., Powderly W. G., Cloud G. A., Robinson P., Grieco M. H., Sharkey P. K., Thompson S. E., Sugar A. M., Tuazon C. U., Fisher J. F. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992 Jan 9;326(2):83–89. doi: 10.1056/NEJM199201093260202. [DOI] [PubMed] [Google Scholar]
  8. Velez J. D., Allendoerfer R., Luther M., Rinaldi M. G., Graybill J. R. Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. J Infect Dis. 1993 Aug;168(2):508–510. doi: 10.1093/infdis/168.2.508. [DOI] [PubMed] [Google Scholar]
  9. Viard J. P., Hennequin C., Fortineau N., Pertuiset N., Rothschild C., Zylberberg H. Fulminant cryptococcal infections in HIV-infected patients on oral fluconazole. Lancet. 1995 Jul 8;346(8967):118–118. doi: 10.1016/s0140-6736(95)92139-7. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES